ALK and anaplastic large cell lymphoma: The analysis of pretreatment anti-ALK antibodies in 95 ALK-positive pediatric ALCL patients, enrolled in clinical studies with comparable short-pulse chemotherapies, confirmed that more than 90% of the patients had measurable anti-ALK antibody titers at diagnosis compared to only one of 99 controls [47].